Abstract
Hypertrophic cardiomyopathy (HCM), characterized by a thickened, fibrotic myocardium with or without a dynamic left ventricular (LV) outflow tract gradient, remains the most common cause of sudden cardiac death in young adults. To date, there is no cure for this condition. Based on animal and clinical data, we hypothesized that atorvastatin would induce LV mass regression.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
